INS and Alzheimer disease: Our results would support this overall conclusion in a TBI model showing that brain insulin resistance would negate the efficacy of insulin as a therapy to provide protection against oligomer-induced synaptic dysfunction in injured animals as well as in AD patients with a history of TBI.